This is a fast-moving area, so here's an honest breakdown: What Happened The FDA declared the semaglutide shortage over (early 2025), meaning compounding pharmacies lost the legal right to compound copies of Ozempic/Wegovy. Many telehealth companies had to pivot quickly. Services Still Navigating This Space Still offering some compounded options (as of early 2025): Hims & Hers - shifted toward "personalized" formulations (different dosages or added ingredients like B12/NAD) LifeMD / GoRx - exploring compliant formulations Mochi Health - working with compounding pharmacies on permitted variations Important Caveats Availability changes weekly - some services have paused compounded semaglutide entirely "Personalized" compounds may face their own scrutiny Tirzepatide (Mounjaro/Zepbound) shortage status differs - compounding may still be permitted there My Honest Recommendation Check Hims & Hers, Ro, and Mochi Health directly Ask specifically about their current legal compliance approach Consider services offering brand-name GLP-1s with manufacturer coupons as an alternative Verify current status directly since this regulatory situation is actively evolving. Would you like help comparing other aspects of these services?
Mentioned in position 3 of 5
Read full answer with sources →